0 16

Cited 0 times in

Changes in Serum IgA Antibody Levels against the Glycopeptidolipid Core Antigen during Antibiotic Treatment of Mycobacterium avium Complex Lung Disease

Authors
 Byung Woo Jhun  ;  Su-Young Kim  ;  Hye Yun Park  ;  Kyeongman Jeon  ;  Sung Jae Shin  ;  Won-Jung Koh 
Citation
 Japanese Journal of Infectious Diseases, Vol.70(5) : 582-585, 2017 
Journal Title
 Japanese Journal of Infectious Diseases 
ISSN
 1344-6304 
Issue Date
2017
MeSH
Aged ; Anti-Bacterial Agents/therapeutic use* ; Antibodies, Bacterial/blood* ; Antigens, Bacterial/immunology* ; Female ; Glycoconjugates/immunology ; Humans ; Immunoglobulin A/blood* ; Lung Diseases/drug therapy ; Lung Diseases/immunology ; Male ; Middle Aged ; Mycobacterium avium Complex/immunology* ; Mycobacterium avium-intracellulare Infection/drug therapy* ; Mycobacterium avium-intracellulare Infection/immunology* ; Treatment Outcome
Keywords
Mycobacterium avium complex ; glycopeptidolipid ; immunoenzyme techniques ; serologic tests ; treatment outcome
Abstract
We evaluated serial changes in the levels of serum immunoglobulin A (IgA) antibody to the glycopeptidolipid (GPL) core antigen during antibiotic treatment in 57 patients with Mycobacterium avium complex (MAC) lung disease at baseline (T0) and after 3 months (T3) and 6 months (T6) of treatment. The median patient age was 59 years, and 37 (65%) patients were women. The etiologic organisms included M. avium in 32 (56%) patients and M. intracellulare in 25 (44%) patients. Seven (12%) patients had the fibrocavitary form of the disease on computed tomography. After 12 months of treatment, 42 (74%) patients had a favorable response to treatment, whereas 15 (26%) patients had an unfavorable response to treatment defined as the absence of sputum culture conversion within 12 months of treatment. The initial median serum anti-GPL IgA levels in the 57 patients was 3.50 U/mL, and the antibody levels at T0 (median 3.50 U/mL), T3 (median 2.71 U/mL), and T6 (median 2.61 U/mL) were significantly decreased following treatment (P < 0.001). The results of the multivariate analysis indicated that an initially elevated anti-GPL IgA level (> 3.50 U/mL) was associated with an unfavorable response (P = 0.049). Our data suggest that elevated anti-GPL IgA levels may reflect disease activity and may help predict treatment response in patients with MAC lung disease.
URI
http://ir.ymlib.yonsei.ac.kr/handle/22282913/161086
DOI
10.7883/yoken.JJID.2016.523
Appears in Collections:
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Microbiology (미생물학교실)
Yonsei Authors
신성재(Shin, Sung Jae)
사서에게 알리기
  feedback
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse